Trial Profile
A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Adocia
- 28 May 2015 According to an Adocia media release, complete data from this trial will be presented at the 75th Scientific Sessions of the American Diabetes Association (ADA).
- 09 Dec 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 10 Sep 2014 Primary endpoints (Insulin area under the concentration time curve, insulin maximum concentration, maximum glucose infusion rate and glucose area under the concentration time curve) have been met